S. Radominski

2.4k total citations
54 papers, 970 citations indexed

About

S. Radominski is a scholar working on Rheumatology, Genetics and Hematology. According to data from OpenAlex, S. Radominski has authored 54 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Rheumatology, 14 papers in Genetics and 14 papers in Hematology. Recurrent topics in S. Radominski's work include Rheumatoid Arthritis Research and Therapies (31 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). S. Radominski is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (31 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). S. Radominski collaborates with scholars based in Brazil, United States and Mexico. S. Radominski's co-authors include Marise Lazaretti‐Castro, Teresa S. Kasamatsu, Victória Zeghbi Cochenski Borba, Emília Inoue Sato, José Gilberto H. Vieira, Stanley Cohen, Alan Kivitz, Cristiano A. F. Zerbini, F. Navarro-Sarabia and Ewa Olech and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Bone.

In The Last Decade

S. Radominski

49 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Radominski Brazil	16	496	251	226	174	141	54	970
Tien‐Tsai Cheng Taiwan	20	650 1.3×	293 1.2×	320 1.4×	65 0.4×	269 1.9×	78	1.5k
Sharon Van Doornum Australia	18	898 1.8×	322 1.3×	206 0.9×	107 0.6×	40 0.3×	35	1.4k
B. A. C. Dijkmans Netherlands	13	1.5k 3.1×	394 1.6×	130 0.6×	312 1.8×	90 0.6×	24	1.9k
Annette Schlemmer Denmark	13	694 1.4×	246 1.0×	239 1.1×	248 1.4×	463 3.3×	21	1.5k
Mike J. Peters Netherlands	18	1.2k 2.4×	367 1.5×	107 0.5×	182 1.0×	37 0.3×	24	1.5k
Kristina Albertsson Sweden	12	756 1.5×	143 0.6×	129 0.6×	237 1.4×	34 0.2×	12	984
Sytske Anne Bergstra Netherlands	15	524 1.1×	139 0.6×	82 0.4×	157 0.9×	55 0.4×	59	759
Tracey E. Toms United Kingdom	23	1.0k 2.1×	247 1.0×	97 0.4×	230 1.3×	20 0.1×	33	1.5k
D E Bax United Kingdom	14	451 0.9×	194 0.8×	82 0.4×	59 0.3×	285 2.0×	22	1.0k
R. Rau Germany	20	1.2k 2.5×	200 0.8×	167 0.7×	440 2.5×	68 0.5×	49	1.5k

Countries citing papers authored by S. Radominski

Since Specialization

Citations

This map shows the geographic impact of S. Radominski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Radominski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Radominski more than expected).

Fields of papers citing papers by S. Radominski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Radominski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Radominski. The network helps show where S. Radominski may publish in the future.

Co-authorship network of co-authors of S. Radominski

This figure shows the co-authorship network connecting the top 25 collaborators of S. Radominski. A scholar is included among the top collaborators of S. Radominski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Radominski. S. Radominski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guimarães, Maria Fernanda Brandão de Resende, Maria Raquel da Costa Pinto, Ana Paula Monteiro Gomides, et al.. (2024). Predictors of serious infections in rheumatoid arthritis—a prospective Brazilian cohort. Advances in Rheumatology. 64(1). 23–23. 3 indexed citations

Gomides, Ana Paula Monteiro, Claiton Viegas Brenol, Ivânio Alves Pereira, et al.. (2024). High-Titer Rheumatoid Factor is Associated with Worse Clinical Outcomes and Higher Needs for Advanced Therapies in Rheumatoid Arthritis Under Real-Life Conditions. Rheumatology and Therapy. 12(1). 123–136.

Bonfiglioli, Karina Rossi, Ana Cristina de Medeiros Ribeiro, Ivânio Alves Pereira, et al.. (2023). Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohort. Advances in Rheumatology. 63(1). 34–34. 8 indexed citations

Albuquerque, Cleandro Pires de, Ana Paula Monteiro Gomides, Rina Dalva Neubarth Giorgi, et al.. (2023). POS0055 BEYOND THE WINDOW: EFFECTS OF LONG-TERM TIGHT CONTROL IN EARLY-TREATED RHEUMATOID ARTHRITIS UNDER REAL-LIFE CONDITIONS. Annals of the Rheumatic Diseases. 82. 237–238. 1 indexed citations

Albuquerque, Cleandro Pires de, Ana Paula Monteiro Gomides, Ana Beatriz Vargas‐Santos, et al.. (2023). Decreasing delays in the diagnosis and treatment of rheumatoid arthritis in Brazil: a nationwide multicenter observational study. Advances in Rheumatology. 63(1). 3–3. 2 indexed citations

Albuquerque, Cleandro Pires de, Ana Paula Monteiro Gomides, Ana Beatriz Vargas‐Santos, et al.. (2023). Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study. Advances in Rheumatology. 63(1). 17–17. 4 indexed citations

Gomides, Ana Paula Monteiro, Cleandro Pires de Albuquerque, Ana Beatriz Vargas‐Santos, et al.. (2020). Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs ‘in’ rheumatoid arthritis. International Journal of Clinical Pharmacy. 43(3). 737–742. 5 indexed citations

Giorgi, Rina Dalva Neubarth, Ana Beatriz Vargas‐Santos, Cleandro Pires de Albuquerque, et al.. (2020). Real - rheumatoid arthritis in real life - study cohort: a sociodemographic profile of rheumatoid arthritis in Brazil. Advances in Rheumatology. 60(1). 20–20. 7 indexed citations

Cohen, Stanley, Rieke Alten, Hideto Kameda, et al.. (2018). A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy. Arthritis Research & Therapy. 20(1). 155–155. 45 indexed citations

10.

Radominski, S., Claiton Viegas Brenol, Cristiano A. F. Zerbini, et al.. (2018). Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis. Medicine. 97(31). e11609–e11609. 7 indexed citations

11.

Citera, Gustavo, Eduardo Mysler, Oscar Rillo, et al.. (2017). Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population. JCR Journal of Clinical Rheumatology. 23(4). 193–199. 13 indexed citations

12.

Zerbini, Cristiano A. F., S. Radominski, Mario H. Cardiel, et al.. (2016). Efficacy and Safety of Tofacitinib Monotherapy Versus Combination Therapy in a Latin American Subpopulation of Patients with Rheumatoid Arthritis: A Pooled Phase 3 Analysis. JCR Journal of Clinical Rheumatology. 1 indexed citations

13.

Radominski, S., Mario H. Cardiel, Gustavo Citera, et al.. (2016). Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies. Reumatología Clínica. 13(4). 201–209. 11 indexed citations

14.

Bone, Henry G., R. Chapurlat, Cesar Libanati, et al.. (2011). Safety observations from denosumab long-term extension and cross-over studies in postmenopausal women with osteoporosis. Open Repository and Bibliography (University of Liège). 3 indexed citations

15.

Papapoulos, Socrates E., Z. Man, Dan Mellström, et al.. (2011). FIVE-YEAR DENOSUMAB TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION. Data Archiving and Networked Services (DANS). 9 indexed citations

16.

Chapurlat, R., Socrates E. Papapoulos, Henry G. Bone, et al.. (2010). Long-term denosumab treatment of postmenopausal women with osteoporosis: results from the first year extension study of the FREEDOM trial. Open Repository and Bibliography (University of Liège). 2 indexed citations

17.

Morales‐Torres, Jorge, et al.. (2010). Fracture risk assessment in Latin America: is Frax™ an adaptable instrument for the region?. Clinical Rheumatology. 29(10). 1085–1091. 10 indexed citations

18.

Borba, Victória Zeghbi Cochenski, José Gilberto H. Vieira, Teresa S. Kasamatsu, et al.. (2008). Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporosis International. 20(3). 427–433. 157 indexed citations

19.

Laurindo, Iêda Maria Magalhães, Geraldo da Rocha Castelar Pinheiro, Antônio Carlos Ximenes, et al.. (2002). Consenso brasileiro para diagnóstico e tratamento da artrite reumatóide. Revista Brasileira de Reumatologia. 355–361. 2 indexed citations

20.

Neto, João Francisco Marques, et al.. (1993). Estudo multicêntrico da prevalência da artrite reumatóide do adulto em amostras da populaçao brasileira. Revista Brasileira de Reumatologia. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact